Predictors of recurrence and survival in lymphovascular space invasion negative early-stage endometrioid endometrial cancer patients

被引:0
|
作者
Altin, Duygu [1 ]
Akinci, Tugce [1 ]
Taskin, Salih [1 ]
Ortac, Firat [1 ]
机构
[1] Ankara Univ Fac Med, Dept Obstet & Gynecol, Ankara, Turkiye
关键词
Endometrial cancer; recurrence; lymphovascular space invasion; survival; POSTOPERATIVE RADIOTHERAPY; PROGNOSTIC-SIGNIFICANCE; HIGH-INTERMEDIATE; CARCINOMA; INVOLVEMENT; MANAGEMENT; PATTERNS; THERAPY; SURGERY; TRIAL;
D O I
10.4274/jtgga.galenos.2023.2022-6-11
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The purpose of this study was to assess prognostic factors correlated with recurrence and decreased oncologic outcomes, as well as the role of adjuvant treatment on survival in women with stage I and II endometrioid endometrial cancer without lymphovascular space invasion (LVSI). Material and Methods: Patients with LVSI negative, early-stage endometrioid endometrial cancer patients were retrospectively reviewed. Multivariable logistic regression models were used for identifying predictors of recurrence. Overall survival (OS) and disease-free survival (DFS) were estimated using the Kaplan-Meier method, and survival curves were compared by log-rank test. Univariable and multivariable analyses were performed to establish factors affecting OS and DFS. Hazard ratios with 95% confidence intervals were calculated. Results: A total of 289 patients were included, with a mean age of 58 years and the median surveillance time of 45 (6-147) months. The majority of the patients (54%) had grade 1 tumors. Adjuvant therapy was administered to 68 (23.5%). A total of 13 (4.5%) recurred with median time to recurrence of 52 months. Patients receiving adjuvant treatment were more likely to recur (p=0.015), and grade was the only independent predictor of recurrence (p=0.029). Five-year OS and DFS were 95.8% and 97.9%, respectively. While tumor size (p=0.018) and grade 3 histology (p=0.045) were related with shorter DFS, age (p<0.001) was the only related factor for decreased OS. Conclusion: Recurrence rate was low among LVSI negative, early-stage endometrioid endometrial cancer patients. Although recurrences were seen more frequently in patients who received adjuvant treatment, it wasn't an independent prognostic factor. Neither recurrence nor adverse uterine risk factors were associated with shorter OS. While age was the only prognostic factor for decreased OS, grade 3 histology and tumor size were associated with decreased DFS.
引用
收藏
页码:261 / 270
页数:10
相关论文
共 50 条
  • [1] Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma
    Nofech-Mozes, Sharon
    Ackerman, Ida
    Ghorab, Zeina
    Ismiil, Nadia
    Thomas, Gillian
    Covens, Al
    Khalifa, Mahmoud A.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (06) : 912 - 917
  • [2] Substantial lymphovascular space invasion predicts worse outcomes in early-stage endometrioid endometrial cancer
    Barnes, Elizabeth A.
    Martell, Kevin
    Parra-Herran, Carlos
    Taggar, Amandeep S.
    Donovan, Elysia
    Leung, Eric
    [J]. BRACHYTHERAPY, 2021, 20 (03) : 527 - 535
  • [3] Lymphovascular space invasion in early-stage endometrial cancer: adjuvant treatment and patterns of recurrence
    van Barneveld, Esther
    Allen, David G.
    Bekkers, Ruud L. M.
    Grant, Peter T.
    [J]. SOUTHERN AFRICAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 8 (01) : 18 - 23
  • [4] The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer
    Fariba Yarandi
    Elham Shirali
    Setare Akhavan
    Fatemeh Nili
    Sara Ramhormozian
    [J]. European Journal of Medical Research, 28
  • [5] The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer
    Yarandi, Fariba
    Shirali, Elham
    Akhavan, Setare
    Nili, Fatemeh
    Ramhormozian, Sara
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [6] Patterns of Recurrence in Stage I Endometrioid Endometrial Adenocarcinoma With Lymphovascular Space Invasion
    Simpkins, Fiona
    Papadia, Andrea
    Kunos, Charles
    Michener, Chad
    Frasure, Heidi
    AbuShahin, Fadi
    Mariani, Andrea
    Bakkum-Gamez, Jamie N.
    Landrum, Lisa
    Moore, Kathleen
    Thomas, Sajeena G.
    Windhorn, Alexandra
    Rose, Peter G.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (01) : 98 - 104
  • [7] Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma
    Ashley E. Veade
    Jonathan Foote
    Jessie Ehrisman
    Gloria Broadwater
    Brittany A. Davidson
    Paula S. Lee
    Angeles Alvarez Secord
    Andrew Berchuck
    Laura J. Havrilesky
    [J]. World Journal of Surgical Oncology, 17
  • [8] Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma
    Veade, Ashley E.
    Foote, Jonathan
    Ehrisman, Jessie
    Broadwater, Gloria
    Davidson, Brittany A.
    Lee, Paula S.
    Secord, Angeles Alvarez
    Berchuck, Andrew
    Havrilesky, Laura J.
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
  • [9] Lymphovascular Space Invasion and the Treatment of Stage I Endometrioid Endometrial Cancer
    van der Putten, Louis J. M.
    Geels, Yvette P.
    Ezendam, Nicole P. M.
    van der Putten, Hans W. H. M.
    Snijders, Marc P. M. L.
    van de Poll-Franse, Lonneke V.
    Pijnenborg, Johanna M. A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (01) : 75 - 80
  • [10] A novel predictive model of lymphovascular space invasion in early-stage endometrial cancer
    Taskum, Ibrahim
    Bademkiran, Muhammed Hanifi
    Cetin, Furkan
    Sucu, Seyhun
    Yergin, Erkan
    Balat, Ozcan
    Ozkaya, Halil
    Uzun, Evren
    [J]. TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 21 (01) : 37 - 42